| Item | Value |
|---|---|
| DrugBank ID | DB08826 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 16 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 2 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 3 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 4 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 5 | beta thalassemia | TxGNN Knowledge Graph |
| 6 | hemosiderosis | TxGNN Knowledge Graph |
| 7 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 8 | hemoglobinopathy | TxGNN Knowledge Graph |
| 9 | hereditary persistence of fetal hemoglobin | TxGNN Knowledge Graph |
| 10 | beta-thalassemia intermedia | TxGNN Knowledge Graph |
| 11 | dominant beta-thalassemia | TxGNN Knowledge Graph |
| 12 | beta-thalassemia and related diseases | TxGNN Knowledge Graph |
| 13 | beta thalassemia | TxGNN Knowledge Graph |
| 14 | hemosiderosis | TxGNN Knowledge Graph |
| 15 | beta-thalassemia HBB/LCRB | TxGNN Knowledge Graph |
| 16 | hemoglobinopathy | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.